Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structural chromosomal abnormalities in human medulloblastoma.

S H Bigner1, J Mark, H S Friedman

  • 1Preuss Laboratory for Brain Tumor Research, Duke University Medical Center, Durham, NC 27710.

Cancer Genetics and Cytogenetics
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinico-pathological description of three paediatric medulloblastoma cases with MLL2/3 gene mutations.

Neuropathology and applied neurobiology·2013
Same author

Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients.

British journal of cancer·2012
Same author

Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation.

Oncogene·2010
Same author

Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study.

British journal of cancer·2009
Same author

Bifunctional DNA alkylator 1,3-bis(2-chloroethyl)-1-nitrosourea activates the ATR-Chk1 pathway independently of the mismatch repair pathway.

Molecular pharmacology·2009
Same author

The gene expression profiles of medulloblastoma cell lines resistant to preactivated cyclophosphamide.

Current cancer drug targets·2008

Karyotypic analysis of human medulloblastomas revealed common chromosomal abnormalities, including i(17q) and partial trisomies of chromosome 1. These findings highlight key genetic alterations in medulloblastoma development.

Area of Science:

  • Cytogenetics
  • Pediatric Oncology
  • Cancer Genomics

Background:

  • Medulloblastoma is a common malignant brain tumor in children.
  • Understanding the genetic basis of medulloblastoma is crucial for diagnosis and treatment.
  • Karyotypic analysis provides insights into chromosomal alterations in cancer.

Purpose of the Study:

  • To investigate the chromosomal abnormalities in human medulloblastoma tumors.
  • To identify recurring karyotypic deviations associated with primary, recurrent, or metastatic medulloblastomas.

Main Methods:

  • Karyotyping of seven human medulloblastomas (four primary, three recurrent/metastatic).
  • Analysis performed on direct preparations and/or short-term/early cultures.
  • Detailed examination of chromosomal stem lines and structural/numerical aberrations.

Related Experiment Videos

Main Results:

  • One tumor exhibited a normal 46,XX stem line.
  • Four tumors showed isochromosome 17q (i(17q)).
  • Three tumors had deletions of extra chromosome 1 copies, leading to partial trisomy 1p/1q.
  • Other abnormalities included chromosome 3 breaks, 20q13 translocations, and double minutes.

Conclusions:

  • Medulloblastomas frequently display gains of whole chromosomes as primary deviations.
  • These gains are often followed by deletions or unbalanced translocations, resulting in partial trisomies.
  • Specific chromosomal aberrations like i(17q) and chromosome 1 alterations are significant in medulloblastoma karyotypes.